NAD+ Oral vs IV vs Injectable: Which Delivery Method Is Best?

The Three Ways to Take NAD+ — and Why Delivery Method Matters

NAD+ supplementation is available in three delivery formats: oral supplements (NMN, NR, NADH, or nicotinic acid tablets), intravenous (IV) infusion at a clinic, and subcutaneous injection at home. Tmates telehealth's injectable NAD+ program at $149/month uses the subcutaneous injection method — and understanding why requires understanding the bioavailability and practical limitations of each format.

Oral NAD+ Supplements (NMN, NR, Nicotinic Acid)

The oral supplement market for NAD+ precursors is large and growing. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are the most common options. Both require conversion to NAD+ through enzymatic pathways in the gut and liver before entering circulation. The primary limitation is conversion efficiency: estimates range from 30–50% conversion of the ingested dose to actual NAD+, with significant variability depending on gut microbiome status, individual enzyme activity, and supplement quality. Oral NAD+ is absorbed from the gut and converted to other compounds (nicotinamide, nicotinic acid) before some fraction eventually reaches intracellular NAD+ pools. Compare specific oral options: NMN vs NAD+, NADH vs NAD+.

IV NAD+ Infusion

Intravenous NAD+ infusion delivers 500–1000mg of NAD+ directly into the bloodstream over 2–4 hours at a clinic. Bioavailability is maximum — 100% of the administered dose reaches circulation. The limitation is practical: each infusion session costs $300–$600 at typical clinics, requires 2–4 hours at a facility, and must be administered by clinical staff. For ongoing supplementation, IV NAD+ is expensive and logistically demanding — not a sustainable home therapy.

Subcutaneous Injectable NAD+ (What Tmates Provides)

Subcutaneous injection of 1000mg NAD+ (200mg/ml, 5ml vial) delivers the coenzyme directly into subcutaneous tissue, from which it is absorbed directly into circulation. Bioavailability is substantially higher than oral forms because there is no gut degradation, no conversion step through hepatic pathways, and absorption is direct and measurable. It is significantly more cost-effective than IV infusion ($149/month versus $300–$600 per clinic session), and self-administration at home requires only the subcutaneous injection technique that patients using GLP-1 medications already know.

Tmates also offers a nasal spray option (300mg/ml) for patients who prefer not to self-inject. Nasal mucosa absorption bypasses gut degradation while avoiding injection, providing bioavailability meaningfully better than oral while being more accessible than injection for some patients. See the nasal spray vs injection comparison for detailed guidance.

Summary: IV infusion offers maximum bioavailability but is impractically expensive for ongoing use. Oral supplements are convenient but have limited conversion efficiency. Subcutaneous injection through Tmates' telehealth approach's anti-aging program provides the best balance of high bioavailability, home convenience, and sustainable cost for ongoing NAD+ restoration. Read full NAD+ injection benefits and how often to inject NAD+.